Tariffs, heavy API reliance on China and India, constant audits, and logistics shocks have made volatility the norm.
This whitepaper distills insights from STAEDEAN’s survey of 130 pharma professionals into clear, actionable steps: where supply chains are most vulnerable, how to accelerate supplier qualification, and how to build true resilience into pharma operations.
Key Takeaways:
Spot vulnerabilities fast: See how your API reliance and GMP risks stack up against peers.
Slash compliance and quality risks: Prevent unqualified suppliers or materials from entering production.
Stay ahead of shocks: Model supply chain risks to stay prepared for disruptions.
Fortify your pharma supply chain, manage risk, and protect margins in times of continuous disruption.
